{"id":"https://openalex.org/W7037529538","doi":null,"title":"The effect of GLP-1 receptor agonist exendin-4 on steatosis in cultured HepG2 human hepatoma cells","display_name":"The effect of GLP-1 receptor agonist exendin-4 on steatosis in cultured HepG2 human hepatoma cells","alternate_titles":[],"publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W7037529538"},"language":"en","primary_location":{"id":"pmh:oai:digitalservices.scranton.edu:p15111coll1/1042","doi":null,"is_oa":false,"landing_page_url":"http://digitalservices.scranton.edu/u?/p15111coll1,1042","pdf_url":null,"source":{"id":"https://openalex.org/S7407064241","display_name":"University of Scranton Digital Collections","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},"parent_works":[],"lineage":["https://openalex.org/W7037529538"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Chen-Liaw, Alice Y.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Chen-Liaw, Alice Y.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exendin-4","display_name":"exendin-4","score":1.0},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9279999732971191},{"id":"https://openalex.org/keywords/hepatic-steatosis","display_name":"hepatic steatosis","score":0.972000002861023},{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.9909999966621399},{"id":"https://openalex.org/keywords/hepg2-cells","display_name":"HepG2 cells","score":0.7760000228881836},{"id":"https://openalex.org/keywords/triglyceride-accumulation","display_name":"triglyceride accumulation","score":0.8500000238418579},{"id":"https://openalex.org/keywords/camp-signaling","display_name":"cAMP signaling","score":0.8669999837875366},{"id":"https://openalex.org/keywords/protein-kinase-a","display_name":"protein kinase A","score":0.8159999847412109},{"id":"https://openalex.org/keywords/linoleic-acid","display_name":"linoleic acid","score":0.7689999938011169},{"id":"https://openalex.org/keywords/oleic-acid","display_name":"oleic acid","score":0.9890000224113464},{"id":"https://openalex.org/keywords/lipogenesis","display_name":"lipogenesis","score":0.796999990940094},{"id":"https://openalex.org/keywords/fatty-acid-beta-oxidation","display_name":"fatty acid beta-oxidation","score":0.843999981880188},{"id":"https://openalex.org/keywords/hepatocyte-viability","display_name":"hepatocyte viability","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7369999885559082},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7138000130653381},{"id":"https://openalex.org/C2776954865","wikidata":"https://www.wikidata.org/wiki/Q1546498","display_name":"Nonalcoholic fatty liver disease","level":4,"score":0.6707000136375427},{"id":"https://openalex.org/C2776175330","wikidata":"https://www.wikidata.org/wiki/Q1365091","display_name":"Steatosis","level":2,"score":0.6449999809265137},{"id":"https://openalex.org/C141359234","wikidata":"https://www.wikidata.org/wiki/Q2734301","display_name":"Lipogenesis","level":3,"score":0.583899974822998},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.5683000087738037},{"id":"https://openalex.org/C2776200302","wikidata":"https://www.wikidata.org/wiki/Q827450","display_name":"Hepatocyte","level":3,"score":0.5530999898910522},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.5040000081062317},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.49480000138282776},{"id":"https://openalex.org/C44353895","wikidata":"https://www.wikidata.org/wiki/Q6556772","display_name":"Lipotoxicity","level":4,"score":0.4478999972343445},{"id":"https://openalex.org/C2781403372","wikidata":"https://www.wikidata.org/wiki/Q207688","display_name":"Oleic acid","level":2,"score":0.38100001215934753},{"id":"https://openalex.org/C41443022","wikidata":"https://www.wikidata.org/wiki/Q27796666","display_name":"Scavenger receptor","level":4,"score":0.3741999864578247},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.3668999969959259},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.36340001225471497},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.3601999878883362},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.35589998960494995},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.35420000553131104},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3531000018119812},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.3303999900817871},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.3190999925136566},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.31529998779296875},{"id":"https://openalex.org/C2779102576","wikidata":"https://www.wikidata.org/wiki/Q5113984","display_name":"Chronic liver disease","level":3,"score":0.31060001254081726},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.30640000104904175},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.29330000281333923},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.29190000891685486},{"id":"https://openalex.org/C2777075537","wikidata":"https://www.wikidata.org/wiki/Q929737","display_name":"Liver disease","level":2,"score":0.2890999913215637},{"id":"https://openalex.org/C176891718","wikidata":"https://www.wikidata.org/wiki/Q1997459","display_name":"Hepatic stellate cell","level":2,"score":0.2847000062465668},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27869999408721924},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2721000015735626},{"id":"https://openalex.org/C543025807","wikidata":"https://www.wikidata.org/wiki/Q61476","display_name":"Fatty acid","level":2,"score":0.2669999897480011},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.2535000145435333}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:digitalservices.scranton.edu:p15111coll1/1042","doi":null,"is_oa":false,"landing_page_url":"http://digitalservices.scranton.edu/u?/p15111coll1,1042","pdf_url":null,"source":{"id":"https://openalex.org/S7407064241","display_name":"University of Scranton Digital Collections","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2735960098","https://openalex.org/W4210880022","https://openalex.org/W2075514437","https://openalex.org/W4225115625","https://openalex.org/W1968002849","https://openalex.org/W2041802771","https://openalex.org/W1965546992","https://openalex.org/W4306920907","https://openalex.org/W1967366495"],"abstract_inverted_index":{"Nonalcoholic":[0],"fatty":[1],"liver":[2,11,25],"disease":[3,12],"(NAFLD)":[4],"is":[5,14,34,223,236,244],"a":[6,29,117,127,178,191,203,212],"serious":[7],"form":[8],"of":[9,20,65,97,115,133,180,215,249,253],"chronic":[10],"that":[13,50,221,238],"characterized":[15,189],"by":[16,71,145,190,247],"the":[17,24,66,94,100,107,112,200,226,239],"abnormal":[18],"accumulation":[19],"triglycerides":[21],"(TG)":[22],"within":[23],"cells,":[26],"resulting":[27],"in":[28,75,123,166,206,208,241],"steatotic":[30,121,161,209],"(\u201cfatty\u201d)":[31],"liver.":[32,108],"NAFLD":[33,70],"highly":[35],"associated":[36],"with":[37,150,175,230],"obesity,":[38],"insulin":[39],"resistance,":[40],"and":[41,69,78,125,141,155,173,185,194,251],"type":[42],"II":[43],"diabetes":[44],"mellitus.":[45],"Previous":[46],"studies":[47,84],"have":[48],"shown":[49],"glucagon-like":[51],"peptide":[52],"1":[53],"(GLP-1)":[54],"as":[55,57],"well":[56],"its":[58,131],"analog":[59],"exendin-4":[60,176,201,222],"can":[61],"ameliorate":[62],"certain":[63],"aspects":[64],"metabolic":[67],"syndrome":[68],"inducing":[72],"weight":[73],"loss":[74],"obese":[76],"mice":[77],"reducing":[79],"hepatic":[80],"TG.":[81],"However,":[82],"those":[83,90],"did":[85],"not":[86],"clearly":[87],"distinguish":[88],"whether":[89],"effects":[91,96],"resulted":[92],"from":[93,103,232],"incretin":[95],"GLP-1":[98,118],"on":[99,106,120,130,147],"pancreas":[101],"or":[102],"direct":[104,113],"action":[105,114],"This":[109],"study":[110,129],"investigates":[111],"exendin-4,":[116],"analog,":[119],"hepatocytes":[122,162,210],"culture":[124],"conducts":[126],"preliminary":[128],"mechanism":[132],"action.":[134],"HepG2":[135],"human":[136],"hepatoma":[137],"cells":[138],"were":[139,163,188],"cultured":[140],"steatosis":[142],"was":[143],"induced":[144],"incubation":[146],"media":[148],"supplemented":[149],"linoleic":[151],"acid":[152,157],"(2":[153,158],"mM)":[154],"oleic":[156],"mM).":[159],"The":[160,197],"then":[164],"pre-incubated":[165],"PKA":[167],"inhibitor":[168],"H89":[169],"for":[170],"30":[171],"minutes":[172],"treated":[174],"over":[177,211],"period":[179,214],"24":[181,216],"hours.":[182,217],"Cell":[183],"viability":[184],"TG":[186,207,243],"content":[187],"TUNEL":[192],"assay":[193],"AdipoRed":[195],"staining.":[196],"results":[198],"demonstrate":[199,220],"induces":[202],"partial":[204],"reduction":[205,240],"treatment":[213],"Results":[218],"also":[219],"acting":[224],"via":[225],"cAMP":[227],"pathway.":[228],"Coupled":[229],"data":[231],"another":[233],"study,":[234],"it":[235],"proposed":[237],"hepatocyte":[242],"driven":[245],"primarily":[246],"downregulation":[248],"lipogenesis":[250],"upregulation":[252],"\u03b2-oxidation.":[254]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7037529538","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2025-10-10T00:00:00"}
